AI in Genomics Market: Pharmaceutical Companies Lead End-Users as Healthcare Providers Drive Clinical Adoption
The [AI in Genomics Market] is powered by a diverse range of end-users, with pharmaceutical companies currently representing the largest segment. Their dominance is due to their significant investment in AI to improve drug discovery and development processes, leveraging genomic data to create more effective and targeted therapies . However, the market is witnessing a significant...
0 Commentarii 0 Distribuiri 118 Views 0 previzualizare